Parallel Fluidics accelerates the pace of discovery for scientific teams with the world's first on-demand microfluidic manufacturing service. By offering production-grade devices from day one, Parallel eliminates the risks that slow down development and provides the shortest path from a concept to a successful microfluidic product. Parallel Fluidics is already making a transformative impact across life sciences verticals such as diagnostics, drug discovery, precision medicine, sequencing, and cell therapy - empowering innovators to accelerate breakthroughs and improve patient outcomes.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/07/24 | $7,000,000 | Seed |
8VC J2 Ventures  Praxis | undisclosed |
